1. Home
  2. IRON vs HUBG Comparison

IRON vs HUBG Comparison

Compare IRON & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • HUBG
  • Stock Information
  • Founded
  • IRON 2017
  • HUBG 1971
  • Country
  • IRON United States
  • HUBG United States
  • Employees
  • IRON N/A
  • HUBG N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • HUBG Oil Refining/Marketing
  • Sector
  • IRON Health Care
  • HUBG Consumer Discretionary
  • Exchange
  • IRON Nasdaq
  • HUBG Nasdaq
  • Market Cap
  • IRON 2.1B
  • HUBG 2.1B
  • IPO Year
  • IRON N/A
  • HUBG 1996
  • Fundamental
  • Price
  • IRON $59.76
  • HUBG $35.02
  • Analyst Decision
  • IRON Strong Buy
  • HUBG Buy
  • Analyst Count
  • IRON 12
  • HUBG 9
  • Target Price
  • IRON $92.08
  • HUBG $43.57
  • AVG Volume (30 Days)
  • IRON 330.3K
  • HUBG 549.5K
  • Earning Date
  • IRON 08-11-2025
  • HUBG 07-31-2025
  • Dividend Yield
  • IRON N/A
  • HUBG 1.43%
  • EPS Growth
  • IRON N/A
  • HUBG N/A
  • EPS
  • IRON N/A
  • HUBG 1.70
  • Revenue
  • IRON N/A
  • HUBG $3,862,113,000.00
  • Revenue This Year
  • IRON N/A
  • HUBG N/A
  • Revenue Next Year
  • IRON N/A
  • HUBG $6.49
  • P/E Ratio
  • IRON N/A
  • HUBG $20.60
  • Revenue Growth
  • IRON N/A
  • HUBG N/A
  • 52 Week Low
  • IRON $30.82
  • HUBG $30.75
  • 52 Week High
  • IRON $68.73
  • HUBG $53.21
  • Technical
  • Relative Strength Index (RSI)
  • IRON 61.73
  • HUBG 50.77
  • Support Level
  • IRON $58.63
  • HUBG $33.63
  • Resistance Level
  • IRON $61.59
  • HUBG $36.00
  • Average True Range (ATR)
  • IRON 2.15
  • HUBG 0.98
  • MACD
  • IRON -0.14
  • HUBG -0.02
  • Stochastic Oscillator
  • IRON 64.07
  • HUBG 39.01

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About HUBG Hub Group Inc.

Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset-light truck brokerage operations along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub often makes tuck-in acquisitions that expand its brokerage, last-mile, and dedicated offerings.

Share on Social Networks: